Related Experiment Video
Updated: Mar 11, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Oral Ondansetron versus Domperidone for Acute Gastroenteritis in Pediatric Emergency Departments: Multicenter Double
Federico Marchetti1, Maurizio Bonati2, Alessandra Maestro3
1Department of Pediatrics, Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy.
Insights
Ondansetron significantly reduced the need for intravenous rehydration in children with gastroenteritis compared to placebo or domperidone. This antiemetic facilitates oral rehydration success when initial attempts fail.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Pharmacology
- Gastroenterology
Background:
- Vomiting associated with acute gastroenteritis in children presents a clinical challenge.
- The efficacy of antiemetics in managing pediatric gastroenteritis remains under investigation.
- Oral rehydration is the primary treatment, but failure necessitates alternative strategies.
Purpose of the Study:
- To compare the effectiveness of ondansetron, domperidone, and placebo in treating vomiting in children with acute gastroenteritis.
- To evaluate the impact of these treatments on the need for intravenous or nasogastric rehydration.
- To determine the optimal antiemetic strategy for children experiencing vomiting refractory to initial oral rehydration.
Main Methods:
- A double-blind, randomized controlled trial involving children aged 1-6 years admitted for gastroenteritis.
- Participants received a single oral dose of ondansetron, domperidone, or placebo after initial oral rehydration failure.
- The primary outcome measured was the rate of subsequent nasogastric or intravenous rehydration.
Main Results:
- Ondansetron use resulted in a >50% reduction in the need for intravenous rehydration compared to both placebo and domperidone.
- 11.8% of children receiving ondansetron required intravenous rehydration versus 25.2% (domperidone) and 28.8% (placebo).
- No significant differences in adverse events were observed across the treatment groups.
Conclusions:
- A single oral dose of ondansetron is effective in reducing the need for intravenous rehydration in children with gastroenteritis who fail initial oral rehydration.
- Ondansetron facilitates the success of oral rehydration and reduces persistent vomiting.
- Domperidone demonstrated no significant benefit for symptomatic treatment of vomiting in this pediatric gastroenteritis cohort.
Abstract:
The use of antiemetics for vomiting in acute gastroenteritis in children is still a matter of debate. We conducted a double-blind randomized trial to evaluate whether a single oral dose of ondansetron vs domperidone or placebo improves outcomes in children with gastroenteritis. After failure of initial oral rehydration administration, children aged 1-6 years admitted for gastroenteritis to the pediatric emergency departments of 15 hospitals in Italy were randomized to receive one oral dose of ondansetron (0.15 mg/kg) or domperidone (0.5 mg/kg) or placebo. The primary outcome was the percentage of children receiving nasogastric or intravenous rehydration. A p value of 0.014 was used to indicate statistical significance (and 98.6% CI were calculated) as a result of having carried out two interim analyses. 1,313 children were eligible for the first attempt with oral rehydration solution, which was successful for 832 (63.4%); 356 underwent randomization (the parents of 125 children did not give consent): 118 to placebo, 119 to domperidone, and 119 to ondansetron. Fourteen (11.8%) needed intravenous rehydration in the ondansetron group vs 30 (25.2%) and 34 (28.8%) in the domperidone and placebo groups, respectively. Ondansetron reduced the risk of intravenous rehydration by over 50%, both vs placebo (RR 0.41, 98.6% CI 0.20-0.83) and domperidone (RR 0.47, 98.6% CI 0.23-0.97). No differences for adverse events were seen among groups. In a context of emergency care, 6 out of 10 children aged 1-6 years with vomiting due to gastroenteritis and without severe dehydration can be managed effectively with administration of oral rehydration solution alone. In children who fail oral rehydration, a single oral dose of ondansetron reduces the need for intravenous rehydration and the percentage of children who continue to vomit, thereby facilitating the success of oral rehydration. Domperidone was not effective for the symptomatic treatment of vomiting during acute gastroenteritis.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
05:33Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drug Dosing: Infants and Children